OMX Nordic 40
2.523,26
PKT
-13,16
PKT
-0,52
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.05.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 19.05.22 | Kone Buy | UBS AG | |
| 19.05.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 19.05.22 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 18.05.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 17.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 17.05.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 13.05.22 | Kone Equal Weight | Barclays Capital | |
| 12.05.22 | Novo Nordisk Overweight | Barclays Capital | |
| 11.05.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 11.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.05.22 | Kone Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.05.22 | Novo Nordisk Outperform | Bernstein Research | |
| 05.05.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.05.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 03.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 03.05.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 02.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.04.22 | Nokia Neutral | Credit Suisse Group | |
| 29.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 29.04.22 | Nokia Buy | UBS AG | |
| 29.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.04.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.04.22 | Novo Nordisk Outperform | Bernstein Research | |
| 29.04.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 28.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 28.04.22 | Nokia Buy | UBS AG | |
| 27.04.22 | Kone Neutral | Goldman Sachs Group Inc. | |
| 27.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 27.04.22 | Kone Buy | Jefferies & Company Inc. | |
| 27.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 26.04.22 | Volvo (B) Sell | UBS AG |